Selective antitumor activity of roscovitine in head and neck cancer.
about
Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner.Genomics and advances towards precision medicine for head and neck squamous cell carcinoma.Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines.
P2860
Selective antitumor activity of roscovitine in head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective antitumor activity of roscovitine in head and neck cancer.
@en
Selective antitumor activity of roscovitine in head and neck cancer.
@nl
type
label
Selective antitumor activity of roscovitine in head and neck cancer.
@en
Selective antitumor activity of roscovitine in head and neck cancer.
@nl
prefLabel
Selective antitumor activity of roscovitine in head and neck cancer.
@en
Selective antitumor activity of roscovitine in head and neck cancer.
@nl
P2093
P2860
P356
P1433
P1476
Selective antitumor activity of roscovitine in head and neck cancer.
@en
P2093
Asel Biktasova
Cyril Gary
Gary Bellinger
Michael Hajek
Natalia Issaeva
Wendell G Yarbrough
P2860
P304
38598-38611
P356
10.18632/ONCOTARGET.9560
P407
P577
2016-05-23T00:00:00Z